As shown (Figure 3F and G), the expression of pulmonary fibrosis markers was significantly upregulated after BLM treatment, and the activation of HCAR1 exacerbated this change, suggesting that the activation of lactate signaling exacerbates the progression of pulmonary fibrosis in vivo. This evidence concerns the gene HCAR1 and pulmonary fibrosis.